The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Abstract
High mobility group 1 (HMGB1) protein is both a nuclear factor and a secreted protein. In the cell nucleus it acts as an architectural chromatin-binding factor that bends DNA and promotes protein assembly on specific DNA targets. Outside the cell, it binds with high affinity to RAGE (the receptor for advanced glycation end products) and is a potent mediator of inflammation. HMGB1 is secreted by activated monocytes and macrophages, and is passively released by necrotic or damaged cells. Here we report that Hmgb1(-/-) necrotic cells have a greatly reduced ability to promote inflammation, which proves that the release of HMGB1 can signal the demise of a cell to its neighbours. Apoptotic cells do not release HMGB1 even after undergoing secondary necrosis and partial autolysis, and thus fail to promote inflammation even if not cleared promptly by phagocytic cells. In apoptotic cells, HMGB1 is bound firmly to chromatin because of generalized underacetylation of histone and is released in the extracellular medium (promoting inflammation) if chromatin deacetylation is prevented. Thus, cells undergoing apoptosis are programmed to withhold the signal that is broadcast by cells that have been damaged or killed by trauma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“So far, six DAMPs have been mechanistically linked to the perception of RCD as immunogenic: (1) calreticulin (CALR) [865, 866], (2) ATP [867–869], (3) high-mobility group box 1 (HMGB1) [870–872], (4) type I IFN [854, 873, 874], (5) cancer cell-derived nucleic acids [864, 875], and (6) annexin A1 (ANXA1) [876].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [871]
In the citing paper
“Although it was initially thought that HMGB1 is released only from the nucleus during primary necrosis, recent data indicate that HMGB1 can be released during secondary necrosis following apoptosis 27,48–50.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [48]
In the citing paper
“Prototypical DAMPs derived from necrotic cells include the chromatin-associated protein high-mobility group box 1 (HMGb1)10, heat shock proteins (HSPs)11, and purine metabolites, such as ATP12 and uric acid13 (TABLE 1).”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [10]
In the citing paper
“In one study, treatment of mice with HMGb1-specific antibodies during acetaminophen-induced liver necrosis ameliorated inflammatory cell recruitment10.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [10]
Citations
Cites
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., & Nagata, S. (1998) · Nature · doi:10.1038/34112 · Cited by 3,239
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
High mobility of proteins in the mammalian cell nucleus
Phair, R. D., & Misteli, T. (2000) · Nature · doi:10.1038/35007077 · Cited by 1,217
Self-citationPhagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Bustin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5237 · Cited by 848
Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation
Abraham, E. H., Arcaroli, J. J., Carmody, A., Wang, H., & Tracey, K. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.2950 · Cited by 692
Dynamic binding of histone H1 to chromatin in living cells
Misteli, T., Gunjan, A., Hock, R., Bustin, M., & Brown, D. T. (2000) · Nature · doi:10.1038/35048610 · Cited by 658
Self-citationCalogero, S., Grassi, F., Aguzzi, A., Voigtländer, T., Ferrier, P., Ferrari, S., & Bianchi, M. E. (1999) · Nature Genetics · doi:10.1038/10338 · Cited by 528
Self-citation
Flagged first, then by citations
1 of the 26 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,019
Role of kidney injury in sepsis
Doi, K. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0146-3 · Cited by 117
Fu, L., Liu, K., Wake, H., Teshigawara, K., Yoshino, T., Takahashi, H. K., Mori, S., & Nishibori, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01325-y · Cited by 115
Jiao, X., Zhang, S., Jiao, J., Zhang, T., Qu, W., Guy, M. M., Kong, B., Zhang, Q. H., & Cui, B. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0719-9 · Cited by 114
Ulfgren, A., Grundtman, C., Borg, K., Alexanderson, H., Andersson, U., Harris, H. E., & Lundberg, I. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20220 · Cited by 112
Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury
Shimamoto, A., Pohlman, T. H., Shomura, S., Tarukawa, T., Takao, M., & Shimpo, H. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.06.079 · Cited by 113
Cancer Usurps Skeletal Muscle as an Energy Repository
Luo, Y., Yoneda, J., Ohmori, H., Sasaki, T., Shimbo, K., Eto, S., KATO, Y. O., Miyano, H., Kobayashi, T., Sasahira, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1052 · Cited by 113
Li, L., Chen, Y., Doan, J., Murray, J. D., Molkentin, J. D., & Liu, Q. (2014) · Circulation · doi:10.1161/circulationaha.114.011195 · Cited by 112
Innate immune memory: Implications for host responses to damage‐associated molecular patterns
Crișan, T. O., Netea, M. G., & Joosten, L. A. B. (2016) · European Journal of Immunology · doi:10.1002/eji.201545497 · Cited by 118
Lee, G., Santo, A. I. E., Zwingenberger, S., Cai, L. X., Vogl, T., Feldmann, M., Horwood, N. J., Chan, J. K.-K., & Nanchahal, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802893115 · Cited by 112
Miksa, M., Wu, R., Dong, W., Komura, H., Amin, D., Ji, Y., Wang, Z., Wang, H., Ravikumar, T. S., Tracey, K. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802994 · Cited by 111
Korbelik, M., Zhang, W., & Merchant, S. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1047-x · Cited by 115
JULIAN, M. W., Shao, G., Bao, S., Knoell, D. L., Papenfuss, T. L., VanGundy, Z., & Crouser, E. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101375 · Cited by 115
Schmidt, S. V., Seibert, S., Walch‐Rückheim, B., Vicinus, B., Kamionka, E.-M., Pahne‐Zeppenfeld, J., Solomayer, E., Kim, Y.-J., Bohle, R. M., & Smola, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3249 · Cited by 112
Toll-like receptor co-receptors as master regulators of the immune response
Gioia, M. D., & Zanoni, I. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.05.008 · Cited by 113
Helicobacter pylori VacA Induces Programmed Necrosis in Gastric Epithelial Cells
Radin, J. N., González‐Rivera, C., Ivie, S. E., McClain, M. S., & Cover, T. L. (2011) · Infection and Immunity · doi:10.1128/iai.01370-10 · Cited by 112
Therapeutic potential of HMGB1-targeting agents in sepsis
Wang, H., Zhu, S., Zhou, R., Li, W., & Sama, A. E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000884 · Cited by 115
DAMPs and inflammatory processes: the role of redox in the different outcomes
Carta, S., Castellani, P., Delfino, L., Tassi, S., Venè, R., & Rubartelli, A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008598 · Cited by 112
Wang, L., Zhang, X., Liu, L., Yang, R., Cui, L., & Li, M. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.030 · Cited by 111
Mitochondria‐mediated caspase‐independent apoptosis induced by cadmium in normal human lung cells
Shih, C.-M., Wu, J., Ko, W., Wang, L.-F., Wei, Y., Liang, H., Chen, Y., & Chen, C. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10488 · Cited by 111
Comparing the effects of different cell death programs in tumor progression and immunotherapy
Messmer, M. N., Snyder, A. G., & Oberst, A. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0214-4 · Cited by 109
Trained immunity in organ transplantation
Ochando, J., Fayad, Z. A., Madsen, J. C., Netea, M. G., & Mulder, W. J. M. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15620 · Cited by 113
Heat Stress-Mediated Activation of Immune–Inflammatory Pathways
Cantet, J. M., Yu, Z., & Ríus, A. G. (2021) · Antibiotics · doi:10.3390/antibiotics10111285 · Cited by 110
Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis
Yang, M., Cao, L., Xie, M., Yu, Y., Kang, R., Yang, L., Zhao, M., & Tang, D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.013 · Cited by 110
Crouser, E. D., Shao, G., JULIAN, M. W., Macre, J. E., Shadel, G. S., Tridandapani, S., Huang, Q., & Wewers, M. D. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a001ae · Cited by 108
Viability of Milk Neutrophils and Severity of Bovine Coliform Mastitis
Mehrzad, J., Duchateau, L., & Burvenich, C. (2004) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(04)73558-4 · Cited by 109
Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
Chiang, C. L.-L., Kandalaft, L. E., & Coukos, G. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.572210 · Cited by 111
Hreggvidsdottir, H. S., Lundberg, A. M., Aveberger, A.-C., Klevenvall, L., Andersson, U., & Harris, H. E. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00327 · Cited by 108
Zeng, W., Shan, W., Gao, L., Gao, D., Hu, Y. W., Wang, G., Zhang, N., Li, Z., Tian, X., Xu, W. L., et al. (2015) · Scientific Reports · doi:10.1038/srep16013 · Cited by 108
Krynetski, E. Y., Krynetskaia, N. F., Bianchi, M. E., & Evans, W. E. (2003) · PubMed · Cited by 108
Self-citationAndersson, U., & Tracey, K. J. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016286 · Cited by 108
Cheema, N., Herbst, A., McKenzie, D., & Aiken, J. M. (2015) · Aging Cell · doi:10.1111/acel.12399 · Cited by 107
Han, J., Zhong, J., Wei, W., Wang, Y., Huang, Y., Yang, P. C., Purohit, S. B., Dong, Z., Wang, M.-H., She, J., et al. (2008) · Diabetes · doi:10.2337/db07-1499 · Cited by 107
Ogiku, M., Kono, H., Hara, M., Tsuchiya, M., & Fujii, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182592 · Cited by 107
Tay, C., Liu, Y.-H., Kanellakis, P., Kallies, A., Li, Y., Cao, A. H., Hosseini, H., Tipping, P. G., Toh, B., Bobik, A., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310678 · Cited by 107
Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
Nishibori, M., Mori, S., & Takahashi, H. K. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.04.006 · Cited by 108
An overview of pathways encoding nociception.
Rodríguez‐Carballeira, M., Solans, R., Larrañaga, J. R., García-Hernández, F. J., Ríos-Fernández, R., Nieto, J., Solanich, X., Martínez‐Valle, F., Fonseca, E., Muñoz, F. J., et al. (2017) · PubMed · Cited by 107
HMGB1 coordinates SASP‐related chromatin folding and RNA homeostasis on the path to senescence
Sofiadis, K., Nikolić, M., Kargapolova, Y., Josipović, N., Zirkel, A., Papadakis, A., Papadionysiou, I., Loughran, G., Keanes, J., Michel, A., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209760 · Cited by 112
“Once received by other cells in the niche, HMGB1 is recognized by RAGE receptors to potently signal inflammation (Scaffidi et al, 2002; Bonaldi et al, 2003; Orlova et al, 2007).”
Armed response: how dying cells influence T‐cell functions
Ferguson, T. A., Choi, J., & Green, D. R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01006.x · Cited by 118
Ohashi, P. S., & DeFranco, A. L. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00406-5 · Cited by 107
DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress
Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor‐Vaknin, N., Moreno‐Villanueva, M., Bürkle, A., Markovitz, D. M., & Ferrando‐May, E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01921-07 · Cited by 108
Jessop, F., Hamilton, R. F., Rhoderick, J. F., Shaw, P. K., & Holian, A. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.08.029 · Cited by 94
Mast Cells Respond to Cell Injury through the Recognition of IL-33
Lunderius-Andersson, C., Enoksson, M., & Nilsson, G. P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00082 · Cited by 109
Luo, Y., Chihara, Y., Fujimoto, K., Sasahira, T., Kuwada, M., Fujiwara, R., Fujii, K., Ohmori, H., & Kuniyasu, H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.016 · Cited by 104
HMGB1 modulates inflammatory responses in LPS-activated macrophages
Gazzar, M. E. (2007) · Inflammation Research · doi:10.1007/s00011-006-6112-0 · Cited by 106
Wang, L., Zhang, X., Liu, L., Cui, L., Yang, R., Li, M., & Du, W. (2010) · Brain Research · doi:10.1016/j.brainres.2009.12.046 · Cited by 106
Lundbäck, P., Lea, J. D., Sowińska, A., Ottosson, L., Fürst, C. M., Stéen, J., Aulin, C., Clarke, J. I., Kipar, A., Klevenvall, L., et al. (2016) · Hepatology · doi:10.1002/hep.28736 · Cited by 107
HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers
Khambu, B., Huda, N., Chen, X., Antoine, D. J., Li, Y., Dai, G., Köhler, U. A., Zong, W., Waguri, S., Werner, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci91814 · Cited by 106
High‐Mobility Group Box‐1 and Liver Disease
Gaskell, H., Ge, X., & Nieto, N. (2018) · Hepatology Communications · doi:10.1002/hep4.1223 · Cited by 104
Maeda, S., Hikiba, Y., Shibata, W., Ohmae, T., Yanai, A., Ogura, K., Yamada, S., & Omata, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.065 · Cited by 106
Au, A. K., Aneja, R. K., Bell, M. J., Bayır, H., Feldman, K., Adelson, P. D., Fink, E. L., Kochanek, P. M., & Clark, R. S. B. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2171 · Cited by 105
miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma
Mathew, L. K., Skuli, N., Mucaj, V., Lee, S. S., Zinn, P. O., Sathyan, P., Imtiyaz, H. Z., Zhang, Z., Davuluri, R. V., Rao, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314341111 · Cited by 105
Santoro, M., Maetzler, W., Stathakos, P., Martin, H. L., Hobert, M. A., Rattay, T. W., Gasser, T., Forrester, J. V., Berg, D., Tracey, K. J., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.018 · Cited by 107
Wang, B., Lian, Y., Su, W., Wei, P., Dong, X. W., Liu, L.-L., Gong, H., Zhang, T., Jiang, C., & Wang, Y. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.017 · Cited by 105
Role of apoptotic and necrotic cell death under physiologic conditions
Han, S. I., Kim, Y.-S., & Kim, T. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.1.001 · Cited by 106
Necrosis is associated with IL-6 production but apoptosis is not
Berghe, T. V., Kalai, M., Denecker, G., Meeus, A., Saelens, X., & Vandenabeele, P. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.003 · Cited by 105
Fadeel, B. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3145-1 · Cited by 105
White matter damage after traumatic brain injury: A role for damage associated molecular patterns
Braun, M., Vaibhav, K., Saad, N., Fatima, S., Vender, J. R., Baban, B., Hoda, M. N., & Dhandapani, K. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.020 · Cited by 108
Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke
He, W., Zhang, Z., & Sha, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121111 · Cited by 102
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Ren, W., Zhao, L., Sun, Y., Wang, X., & Shi, X. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00717-3 · Cited by 110
“…and injury resulting from various stimuli, such as irradiation, hypoxia, and hyperthermia (Pisetsky 2014), soluble HMGB1 can be released into the extracellular space in large quantities by these dead or dying cells and elicit inflammatory responses in vitro and in vivo (Scaffidi et al. 2002).”
BackgroundThe impact of radiation therapy on the antitumor immunity: Local effects and systemic consequences
Lumniczky, K., & Sáfrány, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.024 · Cited by 103
Animal models of idiosyncratic drug reactions
Shenton, J. M., Chen, J., & Uetrecht, J. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.09.001 · Cited by 107
The Devil in the Details: The Emerging Role of Anticitrulline Autoimmunity in Rheumatoid Arthritis
van Gaalen, F. A., Ioan‐Facsinay, A., Huizinga, T. W. J., & Toes, R. E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5575 · Cited by 104
High-mobility group box-1 and its role in angiogenesis
Yang, S., Xu, L., Yang, T., & Wang, F. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.0713412 · Cited by 104
The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development
Zera, K. A., & Buckwalter, M. S. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00844-3 · Cited by 103
“Specifically, HMGB1 released from activated monocytes and macrophages or necrotic cells can bind to the receptor for advanced glycation end products (RAGEs) and toll-like receptors (TLRs) 2 and 4 once secreted into the bloodstream [21, 22].”
BackgroundPais, T. F., Figueiredo, C., Peixoto, R. T., Braz, M. H., & Chatterjee, S. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-43 · Cited by 104
Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification
Taniguchi, N., Yoshida, K., Ito, T., Tsuda, M., Mishima, Y., Furumatsu, T., Ronfani, L., Abeyama, K., Kawahara, K.-I., Komiya, S., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00130-07 · Cited by 101
Self-citationAntoine, D. J., Williams, D. P., Kipar, A., Laverty, H., & Park, B. K. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00126 · Cited by 102
RetractedMolecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
Walker, L. E., Frigerio, F., Ravizza, T., Ricci, E., Tse, K., Jenkins, R. E., Sills, G. J., Jorgensen, A., Porcu, L., Thippeswamy, T., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92001 · Cited by 102
Retractedvan Vloten, J. P., Workenhe, S. T., Wootton, S. K., Mossman, K. L., & Bridle, B. W. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701021 · Cited by 102
Molecular mechanisms of lidocaine
Karnina, R., Arif, S. K., Hatta, M., & Bukhari, A. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102733 · Cited by 110
“HMGB1 is also passively released from necrotic cells, damaged cells, and after extracellular injury [48].”
BackgroundRadisky, D. C., Stallings‐Mann, M. L., Hirai, Y., & Bissell, M. J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2633 · Cited by 102
High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
Castiglioni, A., Canti, V., Rovere, P. Q., & Manfredi, A. A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1033-1 · Cited by 104
Zhang, W., Wang, L.-W., Wang, L., Li, X., Zhang, H., Luo, L., Song, J.-C., & Gong, Z. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2775-x · Cited by 102
Kono, H., Karmarkar, D., Iwakura, Y., & Rock, K. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902485 · Cited by 101
Meng, E., Guo, Z., Wang, H., Jin, J., Wang, J., Wang, H., Wu, C., & Wang, L. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0276 · Cited by 103
Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity
Park, B. K., Laverty, H., Srivastava, A., Antoine, D. J., Naisbitt, D. J., & Williams, D. P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.011 · Cited by 104
Qing, D., Conegliano, D., Shashaty, M. G. S., Seo, J., Reilly, J. P., Worthen, G. S., Huh, D., Meyer, N. J., & Mangalmurti, N. S. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1095oc · Cited by 103
Thrombomodulin as a Physiological Modulator of Intravascular Injury
Watanabe‐Kusunoki, K., Nakazawa, D., Ishizu, A., & Atsumi, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575890 · Cited by 105
“-host disease; HMGB1, High mobility group box 1; HUS, Hemolytic uremic syndrome; IRI, Ischemiareperfusion injury; LPS, Lipopolysaccharide; Mac-1, Macrophage-1 antigen; MPA, Microscopic polyangiitis; MPO, Myeloperoxidase; NETs, Neutrophil extracellular traps; NF-κB, Nuclear factor-kappa B; RAGE, Receptor for advanced g…”
BackgroundInfluentialThe search for novel analgesics: targets and mechanisms
Yaksh, T. L., Woller, S. A., Ramachandran, R., & Sorkin, L. S. (2015) · F1000Prime Reports · doi:10.12703/p7-56 · Cited by 100
Neuroinflammatory mediators in acquired epilepsy: an update
Chen, Y. S., Nagib, M. M., Yasmen, N., Sluter, M. N., Littlejohn, T. L., Yu, Y., & Jiang, J. (2023) · Inflammation Research · doi:10.1007/s00011-023-01700-8 · Cited by 101
“matin-binding protein that exists in two forms: the intracellular form that is involved in the regulation of gene transcription and the extracellular form that acts as a “danger signal” after inflammatory challenges [107, 108].”
BackgroundPenzo, M., Molteni, R., Suda, T., Samaniego, S., Raucci, A., Habiel, D. M., Miller, F. W., Jiang, H.-P., Li, J., Pardi, R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903131 · Cited by 101
Self-citationLi, J., Gong, Q., Zhong, S., Wang, L., Guo, H., Xiang, Y., Ichim, T. E., Wang, C., Chen, S., Gong, F., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq466 · Cited by 101
Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice
Han, R., Frett, E., Levy, J. R., Rader, E. P., Lueck, J. D., Bansal, D., Moore, S. A., Ng, R., de Bernabé, D. B.-V., Faulkner, J. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42390 · Cited by 96
Immunogenic Apoptotic Cell Death and Anticancer Immunity
Vandenabeele, P., Vandecasteele, K., Bachert, C., Krysko, O., & Krysko, D. V. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_6 · Cited by 106
Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases
Bartman, S., Coppotelli, G., & Ross, J. M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46030130 · Cited by 110
“Classical DAMPs include cytoplasmic DNA, heat-shock proteins, and mitochondrial components [105–107].”
BackgroundMoser, B., Desai, D. D., Downie, M. P., Chen, Y., Yan, S. F., Herold, K. C., Schmidt, A. M., & Clynes, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8051 · Cited by 100
da Silva, F. P., & Nizet, V. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0320-3 · Cited by 102
In Vitro Cell Death Determination for Drug Discovery: A Landscape Review of Real Issues
Méry, B., Guy, J., Vallard, A., Espenel, S., Ardail, D., Rodriguez‐Lafrasse, C., Rancoule, C., & Magné, N. (2017) · Journal of Cell Death · doi:10.1177/1179670717691251 · Cited by 104
Bacterial Endotoxin Induces the Release of High Mobility Group Box 1 via the IFN-β Signaling Pathway
Kim, J., Kim, S.-J., Lee, I., Lee, M., Uematsu, S., Akira, S., & Oh, K. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801364 · Cited by 99
High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
Singh, G. B., Zhang, Y., Boini, K. M., & Koka, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143570 · Cited by 103
Sono/Photodynamic Nanomedicine‐Elicited Cancer Immunotherapy
Li, Y., Xie, J., Um, W., You, D. G., Kwon, S., Zhang, L., Zhu, J., & Park, J. H. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202008061 · Cited by 99
Mardi, A., Shirokova, A. V., Mohammed, R. N., Keshavarz, A., Zekiy, A. O., Thangavelu, L. P., Mohammad, T. A. M., Marofi, F., Shomali, N., Zamani, A., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02585-z · Cited by 102
“Subsequently DAMPs such as ATP, HMGB1, CALR, and type I IFNs are released by ICD from dying cancer cells.”
BackgroundInfluentialRadiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
Liu, T., Pei, P., Shen, W., Hu, L. T., & Yang, K. (2023) · Small Methods · doi:10.1002/smtd.202201401 · Cited by 104
Jiang, W., & Pisetsky, D. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3337 · Cited by 100
DeMarco, R., Fink, M. P., & Lotze, M. T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.023 · Cited by 99
Graewe, S., Rankin, K. E., Lehmann, C., Deschermeier, C., Hecht, L., Fröhlke, U., Stanway, R. R., & Heussler, V. T. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002224 · Cited by 104
Monteiro, J. P., Oliveira, P. J., & Jurado, A. S. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.06.002 · Cited by 102
The systemic inflammatory response syndrome
Weigand, M. A., Hörner, C., Bardenheuer, H. J., & Bouchon, A. (2004) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2003.12.005 · Cited by 98
TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant
Saenz, R., Futalan, D., Leutenez, L., Eekhout, F., Fecteau, J. F., Sundelius, S., Sundqvist, S., Larsson, M., Hayashi, T., Minev, B., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-211 · Cited by 100
Giordano, C., Mojumdar, K., Liang, F., Lemaire, C. F., Li, T., Richardson, J., Divangahi, M., Qureshi, S. T., & Petrof, B. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu735 · Cited by 102
Metadata
- Authors
- Scaffidi, P., Misteli, T., & Bianchi, M. E.
- Affiliations
- National Institutes of Health (US)
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Bianchi, Marco E.
- Venue
- Nature
- Published
- 2002-07-11
- Volume
- 418
- Issue
- 6894
- Pages
- 191-195
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004266769
- Cited by
- 4,221
- References
- 26
- Citations by year
- 2026: 104 · 2025: 106 · 2024: 129 · 2023: 158 · 2022: 168 · 2021: 233 · 2020: 204 · 2019: 196 · 2018: 211 · 2017: 205 · 2016: 228 · 2015: 253 · 2014: 276 · 2013: 261 · 2012: 230
- FWCI
- 47.06
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-09-30)
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- HMGB1, necrosis, apoptosis, inflammation, chromatin, histone acetylation, RAGE, extracellular HMGB1 release, secondary necrosis, phagocytosis, damage-associated molecular patterns
- MeSH terms
- Acetylation, Animals, Cell Survival, Chromatin, HeLa Cells, Humans, Inflammation, Necrosis, Protein Binding, Apoptosis, Gene Deletion, HMGB1 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review